FDA report shows casualties from the abortion pill continue to climb
Published percentages for ER visits on mifepristone’s 2023 label indicate that 2.9 to 4.6% of women who take it end up in the emergency room, indicating that abortion pill ER visits could be in the tens of thousands every year. In addition, the FDA’s medication guide acknowledges that as many as seven percent (7%) of women will need surgery after taking mifepristone “to stop bleeding” or to complete the abortion… These percentages, against Guttmacher Institute’s updated 648,500 annual abortion pill data from 2023, reveal that each year, 39,000 to 45,400 women may need additional surgery, and 19,400 to over 32,000 women may report to an emergency department after taking abortion-inducing drugs.